Sting leads campaign against Blair's plan to reclassify cannabis

Sophie Goodchild,Chief Reporter
Sunday 18 December 2005 01:00
Comments

The singer Sting and the veteran actress Jean Simmons are on a list of prominent figures who have written to Tony Blair urging him to keep cannabis as a class C drug following last week's exclusive report in The Independent on Sunday that the Prime Minister was planning a U-turn to toughen up penalties for its use.

The governor of Brixton prison, former Spandau Ballet member Gary Kemp and Mark Oaten, the Liberal Democrat MP, as well as doctors and drug experts have also signed a letter warning against a toughening-up of policy on the drug, which was officially downgraded last January. They are backing a campaign by Release, which provides support for people with drug problems, to keep cannabis in a lower category.

Last week, the IoS reported that drugs advisers had established a link between mental illness and cannabis use. The Advisory Council on the Misuse of Drugs (ACMD) is understood to have concluded there is a risk of psychosis in some cases, although the health risks do not justify cannabis being moved back to class B.

The Government is expected to make an official announcement next month on the future status of the drug, although sources have indicated Mr Blair is keen to reverse the decision to downgrade it taken by David Blunkett.

Release has written to the Prime Minister as well as Charles Clarke, the Home Secretary, urging them not to return cannabis to class B. A copy of the letter, seen by this paper, highlights the fact that cannabis use in Britain has not increased in the first year since reclassification and that nearly 200,000 hours of police time have been saved. It states: "Such a move would simply add to public confusion, inconsistency and the waste of police resources, without delivering any health or social benefits."

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in